These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9800936)

  • 1. Antibodies against copper-oxidised and malondialdehyde-modified low density lipoproteins in pre-eclampsia pregnancies.
    Uotila J; Solakivi T; Jaakkola O; Tuimala R; Lehtimäki T
    Br J Obstet Gynaecol; 1998 Oct; 105(10):1113-7. PubMed ID: 9800936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein.
    Branch DW; Mitchell MD; Miller E; Palinski W; Witztum JL
    Lancet; 1994 Mar; 343(8898):645-6. PubMed ID: 7509433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to oxidised low-density lipoproteins and cardiolipin in pre-eclampsia and eclampsia.
    Bowen RS; Moodley J; Dutton MF; Fickl H
    J Obstet Gynaecol; 2002 Mar; 22(2):123-6. PubMed ID: 12521691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased levels of autoantibodies against copper-oxidized low density lipoprotein, malondialdehyde-modified low density lipoprotein and cardiolipin in patients with rheumatoid arthritis.
    Cvetkovic JT; Wållberg-Jonsson S; Ahmed E; Rantapää-Dahlqvist S; Lefvert AK
    Rheumatology (Oxford); 2002 Sep; 41(9):988-95. PubMed ID: 12209031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Auto antibodies against oxidized low density lipoprotein in severe preeclampsia.
    Jain M; Sawhney H; Aggarwal N; Vashistha K; Majumdhar S
    J Obstet Gynaecol Res; 2004 Jun; 30(3):188-92. PubMed ID: 15210040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies against modified low-density lipoproteins in coronary artery disease.
    Tornvall P; Waeg G; Nilsson J; Hamsten A; Regnström J
    Atherosclerosis; 2003 Apr; 167(2):347-53. PubMed ID: 12818418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum antibodies to oxidised low-density lipoprotein in pre-eclampsia and coronary heart disease.
    Armstrong VW; Wieland E; Diedrich F; Renner A; Rath W; Kreuzer H; Kuhn W; Oellerich M
    Lancet; 1994 Jun; 343(8912):1570. PubMed ID: 7911891
    [No Abstract]   [Full Text] [Related]  

  • 8. Circulating antibodies recognising oxidatively-modified low-density lipoproteins in patients with IgA nephropathy, membranous glomerulonephritis and focal glomerulosclerosis.
    Fornasieri A; Perugini C; Seccia M; Napodano P; D'Amico G; Bellomo G
    J Nephrol; 2002; 15(4):349-57. PubMed ID: 12243363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies against oxidised low-density lipoprotein in hypopituitary patients with growth hormone deficiency.
    Ozbey N; Aydin A; Telci A; Cakatay U
    Endocr J; 2001 Oct; 48(5):579-84. PubMed ID: 11789563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased circulating oxidised low-density lipoprotein and antibodies to oxidised low-density lipoprotein in preeclampsia.
    Arifin R; Kyi WM; Che Yaakob CA; Yaacob NM
    J Obstet Gynaecol; 2017 Jul; 37(5):580-584. PubMed ID: 28358592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation.
    Maggi E; Marchesi E; Ravetta V; Martignoni A; Finardi G; Bellomo G
    J Hypertens; 1995 Jan; 13(1):129-38. PubMed ID: 7759843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of lipoproteins from pre-eclamptic women on umbilical endothelial cell 6-oxo-prostaglandin f1alpha and endothelin 1 synthesis, and nitric oxide synthase 3 mRNA expression.
    Barden A; Beilin LJ; Both K; Ritchie J; Leedman P; Walters BN; Michael CA
    Clin Sci (Lond); 1999 Dec; 97(6):697-706. PubMed ID: 10585897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL.
    Ylä-Herttuala S; Palinski W; Butler SW; Picard S; Steinberg D; Witztum JL
    Arterioscler Thromb; 1994 Jan; 14(1):32-40. PubMed ID: 7506053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased susceptibility to low density lipoprotein oxidation in women with a history of pre-eclampsia.
    Gratacós E; Casals E; Gómez O; Llurba E; Mercader I; Cararach V; Cabero L
    BJOG; 2003 Apr; 110(4):400-4. PubMed ID: 12699802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating autoantibodies recognizing peroxidase-oxidized low density lipoprotein. Evidence for new antigenic epitopes formed in vivo independently from lipid peroxidation.
    Seccia M; Albano E; Maggi E; Bellomo G
    Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):134-40. PubMed ID: 9012648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies against oxidatively modified LDL do not constitute a risk factor for stroke: a nested case-control study.
    Ahmed E; Trifunovic J; Stegmayr B; Hallmans G; Lefvert AK
    Stroke; 1999 Dec; 30(12):2541-6. PubMed ID: 10582975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of autoantibodies against oxidized low-density lipoproteins and of IgG-bound low density lipoproteins in patients with coronary artery disease.
    Boullier A; Hamon M; Walters-Laporte E; Martin-Nizart F; Mackereel R; Fruchart JC; Bertrand M; Duriez P
    Clin Chim Acta; 1995 Jun; 238(1):1-10. PubMed ID: 7554289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies against malondialdehyde-modified lipoprotein(a) in antiphospholipid syndrome.
    Romero FI; Atsumi T; Tinahones FJ; Gómez-Zumaquero JM; Amengual O; Khamashta MA; Hughes GR
    Arthritis Rheum; 1999 Dec; 42(12):2606-11. PubMed ID: 10616007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The low-density lipoprotein (LDL)-associated PAF-acetylhydrolase activity and the extent of LDL oxidation are important determinants of the autoantibody titers against oxidized LDL in patients with coronary artery disease.
    Lourida ES; Papathanasiou AI; Goudevenos JA; Tselepis AD
    Prostaglandins Leukot Essent Fatty Acids; 2006 Aug; 75(2):117-26. PubMed ID: 16843649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of capture assays for different modifications of human low-density lipoprotein.
    Virella G; Derrick MB; Pate V; Chassereau C; Thorpe SR; Lopes-Virella MF
    Clin Diagn Lab Immunol; 2005 Jan; 12(1):68-75. PubMed ID: 15642987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.